PEEP-absorber | Primary analysis: complete PEEP-absorber vs other patients | Secondary analysis: “other patients” classified as high and low PEEP-absorber (3-level variable) | ||||
---|---|---|---|---|---|---|
Complete | Other | p | High | Low | p | |
Number of patients (%) | 33 (33 %) | 67 (67 %) | – | 21 (21 %) | 46 (46 %) | – |
Total PEEP at ZEEP (cmH2O) | 8 ± 3 | 6 ± 2 | <0.001 | 8 ± 3 | 5 ± 1*,# | <0.001 |
Applied PEEP (cmH2O) | 7 ± 2 | 5 ± 2 | 0.001 | 7 ± 2 | 4 ± 0*,# | <0.001 |
Total PEEP with PEEP (cmH2O) | 9 ± 3 | 9 ± 2 | 0.65 | 10 ± 3 | 8 ± 1# | 0.001 |
Female, n (%) | 18 (55 %) | 24 (36 %) | 0.12 | 5 (24 %) | 19 (41 %) | 0.08 |
Age (years) | 74 ± 8 | 70 ± 11 | 0.07 | 71 ± 10 | 69 ± 12 | 0.18 |
Body mass index (kg/m2) | 30 ± 7 | 28 ± 6 | 0.05 | 31 ± 7 | 26 ± 5*,# | 0.002 |
Respiratory rate (1/min) | 16 ± 3 | 22 ± 4 | < 0.001 | 20 ± 3 | 22 ± 4* | <0.001 |
Expiratory time (s) | 2.7 ± 0.7 | 1.5 ± 0.5 | < 0.001 | 1.7 ± 0.5 | 1.4 ± 0.5* | <0.001 |
Minute ventilation (l/min) | 7.1 ± 1.4 | 10.5 ± 2 | < 0.001 | 10 ± 2 | 11.1 ± 2.1* | <0.001 |
Tidal volume (ml/IBW) | 8 ± 1 | 8 ± 1 | 0.94 | 8 ± 1.5 | 8 ± 1.2 | 0.29 |
Resistance (cmH2O∙l−1∙s) | 21 ± 5 | 18 ± 7 | 0.05 | 20 ± 9 | 18 ± 6* | 0.03 |
Elastance (cmH2O/l) | 20 ± 5 | 19 ± 6 | 0.25 | 19 ± 6 | 18 ± 6 | 0.47 |
Flow limitation, n (%) | 32 (97 %) | 29 (47.8 %) | <0.001 | 19 (90 %) | 10 (22 %)*,# | <0.001 |
Chronic pulmonary disease, n (%) | 25 (76 %) | 22 (33 %) | <0.001 | 12 (57 %) | 10 (22 %)*,# | <0.001 |
History of smoking, n (%) | 24 (75 %) | 24 (38 %) | <0.001 | 9 (45 %) | 15 (34 %) * | 0.002 |
Acute pulmonary disease, n (%) | 27 (84 %) | 25 (37 %) | <0.001 | 12 (57 %) | 13 (28 %)* | <0.001 |
PaO2/FIO2 (mmHg) | 203 ± 82 | 275 ± 132 | 0.01 | 205 ± 89 | 306 ± 137*,# | <0.001 |
Supine position, n (%) | 21 (64 %) | 31 (46 %) | 0.16 | 10 (48 %) | 21 (46 %) | 0.26 |